EXPERIENCE A
DIFFERENT WAY TO TREAT
BULLOUS PEMPHIGOID (BP)
DUPIXENT is the first and only
FDA-approved targeted therapy for
adults with bullous pemphigoid.
Patient portrayal
WHY DUPIXENT
FOR ADULTS WITH
BULLOUS PEMPHIGOID?
Not a steroid or an
immunosuppressant
Targets a key source of underlying
inflammation that may contribute to BP
May help achieve sustained remission*
and reduce itch
*That means there are no new blisters, old ones are healing, and steroids are tapered off by Week 16, with no relapses
from Week 16 to Week 36, and no rescue treatment through Week 36. This analysis was not statistically significant.
Financial Support
Copay Card Program
With the DUPIXENT MyWay® Copay Card, commercially insured patients may pay as little as $0† copay per fill of DUPIXENT. If you’re eligible, you can sign up online and your card will be sent via email. View full copay card Terms & Restrictions.
DUPIXENT MyWay
Patient Assistance Program‡
May be able to help you if you do not have
health insurance, are experiencing difficulty
paying for your DUPIXENT treatment or have
Medicare Part D.
For financial support information, dial
1‑844‑DUPIXENT
(1-844-387-4936), option 1
Monday-Friday, 8 am-9 pm ET
†Subject to the program maximum per patient per calendar year. Approval is not guaranteed. THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs, including any state pharmaceutical assistance programs. This program is not valid where prohibited by law, taxed, or restricted. DUPIXENT MyWay reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Any savings provided by the program may vary depending on patients’ out-of-pocket costs. The program is intended to help patients afford DUPIXENT. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms. Additional terms and conditions apply.
‡Eligible commercial patients and Medicare patients without the Part D (pharmacy) benefit may receive free shipments of up to an 84-day supply of DUPIXENT (for up to 12 months). Patients may reapply after 12 months if they still meet the eligibility criteria. Patients with Medicare Part D who meet eligibility criteria must reapply for the Patient Assistance Program each calendar year, or by December 31st for eligibility consideration for the following year. The assistance period for Medicaid patients varies based on the eligibility criteria. Please note that DUPIXENT MyWay reserves the right to make eligibility determinations, monitor participation, ensure equitable product availability, and modify or discontinue the DUPIXENT MyWay Patient Assistance Program at any time without notice.
What Causes
the ITCH AND BLISTERS?
Dealing with BP can be frustrating, especially when the cause is unknown.
Get the information you need about your condition.